| Completed | A Clinical Study to Evaluate an Experimental Universal Influenza Vaccine, INFLUENZA G1 mHA, in Healthy Adults Influenza Prevention | Phase 1 / Phase 2 | 2023-05-17 |
| Terminated | A Study of Various Respiratory Syncytial Virus (RSV) Pre-Fusion (preF)-Based Vaccine Formulations in Adults Ag Respiratory Syncytial Virus-associated Lower Respiratory Tract Disease Prevention | Phase 1 / Phase 2 | 2022-04-13 |
| Completed | A Study of Ad26.COV2.S and Influenza Vaccines in Healthy Adults COVID-19 Prevention | Phase 3 | 2021-11-02 |
| Completed | A Study of an Ad26.RSV.PreF-based Regimen at the End of Shelf-life in Adults Aged 60 to 75 Years Respiratory Syncytial Virus Prevention | Phase 3 | 2021-11-01 |
| Completed | A Study Evaluating the Immunogenicity of Different Clinical Trial Materials of Ad26.RSV.preF- Based Vaccine in Respiratory Syncytial Virus Prevention | Phase 3 | 2021-10-08 |
| Completed | A Study of an Ad26.RSV.preF-based Vaccine and High-dose Seasonal Influenza Vaccine, With and Without Coadminis Influenza, Human Prevention, Respiratory Syncytial Viruses Prevention | Phase 3 | 2021-10-04 |
| Completed | A Study of an Ad26.RSV. preF-based Vaccine in Adults Aged 18 to 59 Years, Including Adults at High Risk for Se Respiratory Syncytial Virus Infection Prevention | Phase 3 | 2021-09-29 |
| Completed | A Study to Evaluate Different Dose Levels of Ad26.COV2.S in Healthy Adolescents From 12 to 17 Years Inclusive Coronavirus Disease-2019 (COVID-19) Prevention | Phase 2 | 2021-09-27 |
| Completed | A Study of Ad26.COV2.S in Healthy Pregnant Participants (COVID-19) COVID-19 Prevention | Phase 2 | 2021-08-27 |
| Completed | A Study of Ad26.COV2.S Administered as Booster Vaccination in Adults Who Have Previously Received Primary Vacc Coronavirus Disease | Phase 2 | 2021-08-06 |
| Completed | A Study of an Adenovirus Serotype 26 Pre-fusion Conformation-stabilized F Protein (Ad26. RSV. preF) Based Resp Respiratory Syncytial Viruses, Lower Respiratory Tract Disease | Phase 3 | 2021-07-21 |
| Completed | A Study to Evaluate Dose Levels of Ad26.COV2.S Administered as a Two-dose Schedule in Healthy Adults COVID-19 Prevention | Phase 3 | 2021-06-18 |
| Completed | A Study of Ad26.COV2.S in Healthy Adults (COVID-19) Healthy | Phase 1 | 2021-05-25 |
| Completed | A Study of Ad26.COV2.S for the Prevention of SARS-CoV-2-mediated COVID-19 in Adults Participants With or Without Stable Co-morbidities Associated With Progression to Severe COVID-19 | Phase 3 | 2020-11-12 |
| Completed | A Study of a 2-dose Ebola Vaccine Regimen of Ad26.ZEBOV Followed by MVA-BN-Filo in Healthy Pregnant Women Healthy | Phase 3 | 2020-10-05 |
| Completed | A Study of Ad26.COV2.S for the Prevention of SARS-CoV-2-Mediated COVID-19 in Adult Participants Participants With or Without Stable Co-morbidities Associated With Progression to Severe COVID-19 at Different Stages of the Protocol | Phase 3 | 2020-09-07 |
| Completed | A Study to Evaluate a Range of Dose Levels and Vaccination Intervals of Ad26.COV2.S in Healthy Adults and Adol Healthy | Phase 2 | 2020-08-28 |
| Completed | A Study to Evaluate a Range of Dose Levels of an Adenovirus Serotype 26 (Ad26.RSV.preF)-Based Vaccine in Older Healthy | Phase 2 | 2020-07-16 |
| Completed | A Study of Ad26.COV2.S in Adults (COVID-19) Covid-19 Prevention | Phase 1 / Phase 2 | 2020-07-15 |
| Completed | A Study of 2-dose Vaccine Regimen Using 3 Consecutive Lots of Ad26.ZEBOV and MVA-BN-Filo in Adult Participants Ebola | Phase 3 | 2020-02-18 |
| Completed | A Study of Heterologous Vaccine Regimen of Adenovirus Serotype 26 Mosaic4 Human Immunodeficiency Virus(Ad26.Mo Healthy | Phase 3 | 2019-10-31 |
| Completed | A Study of 2-dose Vaccination Regimen of Ad26.ZEBOV and MVA-BN-Filo in Infants Ebola Virus Disease | Phase 2 | 2019-08-19 |
| Terminated | A Study of an Ad26.RSV.preF-based Regimen in the Prevention of Reverse Transcriptase Polymerase Chain Reaction Respiratory Syncytial Viruses, Respiratory Tract Diseases | Phase 2 | 2019-08-01 |
| Completed | A Study to Evaluate the Safety, Reactogenicity, and Immunogenicity of Adenovirus Serotype 26 Based Respiratory Respiratory Syncytial Virus | Phase 1 / Phase 2 | 2019-01-21 |
| Completed | A Shedding Study of Adenovirus Serotype 26 Based Respiratory Syncytial Virus Pre-fusion F Protein (Ad26.RSV.pr Healthy | Phase 1 | 2019-01-07 |
| Terminated | Safety, Reactogenicity and Immunogenicity of Adenovirus Serotype 26 (Ad26)- and Modified Vaccinia Ankara (MVA) Human Papillomavirus Infections | Phase 1 / Phase 2 | 2018-09-27 |
| Completed | A Study to Assess the Safety, Reactogenicity and Immunogenicity of a Trivalent Inactivated Poliovirus Vaccine Healthy | Phase 2 | 2018-07-31 |
| Completed | A Study to Evaluate the Safety and Immunogenicity for Regimen Selection of Ad26.RSV.preF and/or RSV preF Prote Healthy | Phase 1 / Phase 2 | 2018-07-06 |
| Completed | A Study of 2 Different Regimens of Tetravalent Ad26.Mos4.HIV Prime Followed by Boost With Modified Vaccinia An Human Immunodeficiency Virus | Phase 1 | 2018-03-05 |
| Completed | A Study to Evaluate the Safety and Immunogenicity of Seasonal Influenza Vaccine and an Adenovirus Serotype 26- Healthy | Phase 2 | 2017-12-07 |
| Completed | A Study to Evaluate the Safety, Tolerability and Immunogenicity of an Investigational RSV Vaccine Candidate (A Respiratory Syncytial Viruses, Respiratory Tract Infections | Phase 1 / Phase 2 | 2017-11-29 |
| Completed | A Study to Evaluate the Safety, Reactogenicity and Immunogenicity of Ad26.ZIKV.001 in Healthy Adult Volunteers Healthy | Phase 1 | 2017-11-26 |
| Terminated | A Study to Assess the Efficacy of a Heterologous Prime/Boost Vaccine Regimen of Ad26.Mos4.HIV and Aluminum Pho HIV-1 | Phase 2 | 2017-11-03 |
| Completed | An Exploratory Study to Evaluate the Prophylactic Efficacy of a Single Immunization of Ad26.RSV.preF Against R Healthy | Phase 2 | 2017-10-16 |
| Completed | A First in Human Study to Assess the Safety, Tolerability and Immunogenicity of a Single Dose of a Trivalent I Healthy | Phase 1 | 2017-10-09 |
| Completed | A Safety, Tolerability and Immunogenicity Study of 2 Different Regimens of Tetravalent Ad26.Mos4.HIV Prime Fol Healthy | Phase 1 / Phase 2 | 2017-03-31 |
| Completed | A Study to Evaluate the Safety, Tolerability and Immunogenicity of Two Vaccinations of Ad26.RSV.preF One Year Healthy | Phase 1 | 2016-11-08 |
| Completed | Safety and Efficacy Study of Vaccine Schedule With Ad26.Mos.HIV and MVA-Mosaic in Human Immunodeficiency Virus Human Immunodeficiency Virus | Phase 1 / Phase 2 | 2016-09-01 |
| Completed | A Study to Evaluate Safety, Tolerability, and Immunogenicity of Heterologous Prime-boost Regimens Using the Mu Healthy | Phase 1 | 2016-08-01 |
| Completed | Safety, Tolerability and Immunogenicity Study of Different Vaccine Regimens of Trivalent Ad26.Mos.HIV or Tetra Healthy | Phase 1 / Phase 2 | 2016-07-08 |
| Terminated | Long-term Safety Follow-up of Participants Exposed to the Candidate Ebola Vaccines Ad26.ZEBOV and/or MVA-BN-Fi Hemorrhagic Fever, Ebola | Phase 3 | 2016-05-31 |
| Completed | Safety, Tolerability and Immunogenicity Study of Different Vaccine Schedules With Ad26.Mos.HIV and Clade C Gly Healthy | Phase 1 | 2016-03-28 |
| Completed | Safety, Tolerability and Immunogenicity Study of 2-dose Heterologous Regimens for Ebola Vaccines Ad26.ZEBOV/MV Hemorrhagic Fever, Ebola | Phase 2 | 2015-12-10 |
| Completed | Safety, Tolerability and Immunogenicity Study of 3 Prime-boost Regimens for Ebola Vaccines Ad26.ZEBOV/MVA-BN-F Hemorrhagic Fever, Ebola | Phase 2 | 2015-11-06 |
| Completed | Staged Phase 3 Study to Assess the Safety and Immunogenicity of Ebola Candidate Vaccines Ad26.ZEBOV and MVA-BN Ebola Virus Disease | Phase 3 | 2015-09-30 |
| Completed | A Study to Evaluate A Range of Dose Levels of Ad26.ZEBOV and MVA-BN-Filo in Healthy Adult Participants Healthy | Phase 3 | 2015-09-21 |
| Completed | A Study to Assess Safety, Tolerability, and Immunogenicity of Three Heterologus 2-dose Regimens of the Candida Ebola Viral Disease | Phase 2 | 2015-06-15 |
| Completed | A Safety and Immunogenicity Study of Heterologous and Homologous Prime-Boost Ebola Vaccine Regimens in Healthy Healthy | Phase 1 | 2015-01-08 |
| Completed | Safety, Tolerability, and Immunogenicity Study of Homologous Ad26 Mosaic Vector Vaccine Regimens or Heterologo Healthy | Phase 1 / Phase 2 | 2014-12-22 |